LEBANON, Ind. — A $4.5 billion Eli Lilly and Company research and manufacturing facility is coming to Lebanon's LEAP district, the company announced Wednesday.
The Lilly Medicine Foundry, scheduled to open in late 2027, "will combine research, manufacturing and the latest technology to innovate new production methods and scale global access to clinical supply for Lilly's growing pipeline," the company said in its announcement.
Lilly said the facility will expand the company's investment in the LEAP Research and Innovation District to over $13 billion. The pharmaceutical giant previously said it was investing $9 billion in a manufacturing site there to boost production for Zepbound and Mounjaro, which are used to treat diseases such as obesity and type 2 diabetes.
“In addition to supplying high-quality medicine for our clinical studies, this new complex will further strengthen our process development and scale up our manufacturing capabilities to speed delivery of next-generation medicines to patients around the world," Lilly Chair and CEO David A. Ricks said in a statement.
The company said the facility will help it "optimize manufacturing process" while reducing costs and impact on the environment, and touted the facility's flexible design in enabling production of molecular therapies.
The State of Indiana is offering Eli Lilly economic incentives tied to its investment and employment goals, the company said, and will also provide infrastructure improvements for roads, water, electricity and utilities tied to the facility.
Four hundred full-time jobs including scientists, engineers, lab technicians and operations personnel are expected to be added with the the Lilly Medicine Foundry.
"Lilly’s continued investment in Indiana solidifies our state’s role as a hub for cutting-edge science and technology," Indiana Gov. Eric Holcomb said in a statement. "For nearly 150 years, Lilly has been committed to growing its roots and reach in Indiana, cultivating local talent, and driving scientific advancements that benefit patients around the world. I couldn’t be more excited about the opportunities Lilly’s Medicine Foundry will bring to communities throughout our great state."
